Glenview Capital Management’s Cytek Biosciences CTKB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-500,000	Closed	-$5.37M	–	55
2022 Q2	$5.37M	Buy	500,000 +444,587	+802%	+$4.77M	0.13%	48
2022 Q1	$597K	Buy	+55,413	New	+$597K	0.01%	58